CIBC Global Asset Management »

Lexicon Pharmaceuticals shares owned by CIBC Global Asset Management

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by CIBC Global Asset Management from 13F filings

Historical chart of CIBC Global Asset Management investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by CIBC Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by CIBC Global Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $45k 40k 1.15

More positions owned by CIBC Global Asset Management

Rbc Cad (RY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Cibc Cad (CM)
Barrick Mng Corp Com Shs (B)
Amazon (AMZN)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Bk Nova Cad (BNS)
Shopify Cl A Sub Vtg Shs (SHOP)
Alphabet Cap Stk Cl A (GOOGL)
Enbridge (ENB)

View all positions for CIBC Global Asset Management

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
FMR
Vanguard Group
Millennium Management
BlackRock
Citadel Advisors
UBS Group
Sessa Capital IM
Geode Capital Management
Atlantic Trust
Caption Management
Marshall Wace
Susquehanna International
Charles Schwab Investment Management

View all funds holding Lexicon Pharmaceuticals